Vijesti
Vijesti
- Europe closes sharply higher on US data
24.06.2022 / 17:31 - TeleTrader - US consumer sentiment worsens to record low in June
24.06.2022 / 16:02 - TeleTrader - Europe opens higher amid gas worries, new economic data
24.06.2022 / 09:03 - TeleTrader - Bavarian Nordic Announces License and Supply Agreement with Nuance Pharma on the Development and Commercialization of Respiratory Syncytial Virus (RSV) Vaccine for Adults in China and Selected Asian Markets
21.03.2022 / 07:26 - GlobeNewswire - Bavarian Nordic Reports Additional Positive Phase 2 Results for its COVID-19 Vaccine Candidate Ahead of Phase 3 Trial
28.02.2022 / 07:30 - GlobeNewswire - Nasdaq Announces Retirement of Market Technology EVP Lars Ottersgård; Appoints New Leadership to Anti-Financial Crime and Market Infrastructure Technology Businesses
14.02.2022 / 13:45 - GlobeNewswire - Bavarian Nordic Announces Breakthrough Therapy Designation for its RSV Vaccine Candidate for the Prevention of Respiratory Syncytial Virus in Older Adults
14.02.2022 / 08:00 - GlobeNewswire - Bavarian Nordic Commits to Initiating Phase 3 Trial of RSV Vaccine Candidate and to Strengthening its Capital Base
06.12.2021 / 07:37 - GlobeNewswire - Bavarian Nordic Reports Positive Topline Phase 2 Results for its COVID-19 Vaccine Candidate
05.12.2021 / 18:21 - GlobeNewswire - Bavarian Nordic Reports Positive Results from Human Challenge Trial of its RSV Vaccine Candidate
01.09.2021 / 08:01 - GlobeNewswire
u realnom vremenu